Suppr超能文献

哌唑嗪在健康与疾病状态下的蛋白结合情况。

Prazosin protein binding in health and disease.

作者信息

Rubin P, Blaschke T

出版信息

Br J Clin Pharmacol. 1980 Feb;9(2):177-82. doi: 10.1111/j.1365-2125.1980.tb05830.x.

Abstract

Experiments have been performed using equilibrium dialysis to determine the binding of [C]-prazosin to albumin, to α-acid glycoprotein and to the plasma proteins of normal subjects and of patients with cirrhosis, chronic renal failure or chronic heart failure. The influence of propranolol on prazosin binding has been studied. In addition, red blood cell to plasma partitioning of prazosin has been quantified. The dissociation constant for prazosin binding to albumin was 3 × 10 M and to α-acid glycoprotein was 1.9 × 10 M. In fourteen normal subjects the free fraction of prazosin was 0.051 ± 0.007. In seven patients with cirrhosis free fraction of prazosin was 0.064 ± 0.017 ( < 0.05 compared to normal). In nine patients with chronic renal failure the free fraction was 0.077 ± 0.033 ( < 0.05) and in eight congestive heart failure patients the value was 0.064 ± 0.027 ( > 0.05). The range of prazosin free fraction was substantially greater in the patients than in normal subjects. In cirrhotic patients free fraction of prazosin correlated significantly ( = -0.92) with albumin concentration. Propranolol did not influence prazosin protein binding. In blood 20% of prazosin is associated with red cells. The considerably greater range of prazosin free fraction in the patients suggests that caution should be used when prescribing the drug for subjects with these conditions. Both albumin and the acute phase reactant α-acid glycoprotein bind prazosin

摘要

已进行实验,采用平衡透析法测定[C] - 哌唑嗪与白蛋白、α - 酸性糖蛋白以及正常受试者和肝硬化、慢性肾衰竭或慢性心力衰竭患者血浆蛋白的结合情况。研究了普萘洛尔对哌唑嗪结合的影响。此外,还对哌唑嗪在红细胞与血浆之间的分配进行了定量分析。哌唑嗪与白蛋白结合的解离常数为3×10⁻⁶M,与α - 酸性糖蛋白结合的解离常数为1.9×10⁻⁶M。在14名正常受试者中,哌唑嗪的游离分数为0.051±0.007。7名肝硬化患者中哌唑嗪的游离分数为0.064±0.017(与正常相比P<0.05)。9名慢性肾衰竭患者的游离分数为0.077±0.033(P<0.05),8名充血性心力衰竭患者的该值为0.064±0.027(P>0.05)。患者中哌唑嗪游离分数的范围明显大于正常受试者。在肝硬化患者中,哌唑嗪的游离分数与白蛋白浓度显著相关(r = -0.92)。普萘洛尔不影响哌唑嗪与蛋白质的结合。在血液中,20%的哌唑嗪与红细胞结合。患者中哌唑嗪游离分数范围明显更大,这表明在为这些疾病患者开此药时应谨慎。白蛋白和急性期反应物α - 酸性糖蛋白均可结合哌唑嗪

相似文献

1
Prazosin protein binding in health and disease.哌唑嗪在健康与疾病状态下的蛋白结合情况。
Br J Clin Pharmacol. 1980 Feb;9(2):177-82. doi: 10.1111/j.1365-2125.1980.tb05830.x.
2
Absence of effect of heparin on the binding of prazosin and phenytoin to plasma proteins.
Biochem Pharmacol. 1980 Dec;29(24):3337-40. doi: 10.1016/0006-2952(80)90315-9.
3
Protein binding properties of prazosin.
Res Commun Chem Pathol Pharmacol. 1979 Jul;25(1):189-92.
4
Effect of low doses of heparin on the plasma binding of phenytoin and prazosin in normal man.
Eur J Clin Pharmacol. 1983;25(2):211-4. doi: 10.1007/BF00543793.
5
Pharmacokinetics of prazosin in man.哌唑嗪在人体中的药代动力学。
J Clin Pharmacol. 1978 Aug-Sep;18(8-9):402-6. doi: 10.1002/j.1552-4604.1978.tb02456.x.
6
Effect of heparin on the red blood cell-to-plasma concentration ratio of diphenylhydantoin and prazosin.
Ther Drug Monit. 1983;5(4):497-9. doi: 10.1097/00007691-198312000-00019.
8
Prazosin kinetics and effectiveness in renal failure.哌唑嗪在肾衰竭中的动力学及疗效
Clin Pharmacol Ther. 1980 Jun;27(6):779-83. doi: 10.1038/clpt.1980.110.
10
Priapism--side-effect of prazosin in patients with renal failure.
Acta Med Scand. 1983;213(4):319-20. doi: 10.1111/j.0954-6820.1983.tb03743.x.

引用本文的文献

2
Clinical pharmacokinetics of prazosin.哌唑嗪的临床药代动力学
Clin Pharmacokinet. 1980 Jul-Aug;5(4):365-76. doi: 10.2165/00003088-198005040-00004.
3
Alteration of drug-protein binding in renal disease.肾脏疾病中药物与蛋白质结合的改变。
Clin Pharmacokinet. 1984 Jan;9 Suppl 1:18-26. doi: 10.2165/00003088-198400091-00003.
5
Effect of low doses of heparin on the plasma binding of phenytoin and prazosin in normal man.
Eur J Clin Pharmacol. 1983;25(2):211-4. doi: 10.1007/BF00543793.
6
Clinical pharmacokinetics of prazosin--1985.哌唑嗪的临床药代动力学——1985年。
Clin Pharmacokinet. 1985 Mar-Apr;10(2):144-54. doi: 10.2165/00003088-198510020-00002.

本文引用的文献

1
The plasma protein binding of amphetamine, catecholamines and related compounds.
Acta Pharmacol Toxicol (Copenh). 1970;28(3):209-14. doi: 10.1111/j.1600-0773.1970.tb00546.x.
3
Methadone binding to human plasma albumin.美沙酮与人血浆白蛋白的结合
Science. 1972 May 5;176(4034):525-6. doi: 10.1126/science.176.4034.525.
4
The binding of drugs to plasma proteins from patients with poor renal function.
Clin Pharmacokinet. 1976;1(2):121-5. doi: 10.2165/00003088-197601020-00003.
6
Pharmacokinetics of prazosin in man.哌唑嗪在人体中的药代动力学。
J Clin Pharmacol. 1978 Aug-Sep;18(8-9):402-6. doi: 10.1002/j.1552-4604.1978.tb02456.x.
7
Prazosin determination by high-pressure liquid chromatography using fluorescence detection.
J Chromatogr. 1979 Apr 21;172:313-8. doi: 10.1016/s0021-9673(00)90967-1.
8
Protein binding and kinetics of drugs in liver diseases.肝脏疾病中药物的蛋白结合与动力学
Clin Pharmacokinet. 1977 Jan-Feb;2(1):32-44. doi: 10.2165/00003088-197702010-00003.
10
Increased plasma binding of quinidine after surgery: a preliminary report.
Eur J Clin Pharmacol. 1976;10(6):441-4. doi: 10.1007/BF00563081.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验